HEALTHTECH FUNDING EXPERTS
Secure HealthTech Funding During Expensive Clinical Phases
Trusted by HealthTech companies securing funding from:
HealthTech Development Costs Are Crushing Innovation
With clinical trials costing $1B+ and 90% failure rates, non-dilutive funding is critical for survival
Massive Development Costs
Clinical trials, regulatory approval, and validation studies require enormous capital during revenue-free periods.
High Failure Rates
90% of healthcare innovations fail to reach market, making equity dilution extremely risky for founders.
Regulatory Complexity
FDA pathways, clinical protocols, and health system adoption create unique funding requirements.
Cross-Border Blindness
Most US companies ignore $6.4B in Canadian health innovation funding from CIHR and provincial programs.
The Strategic Approach for HealthTech Success
We understand both the technology and regulatory landscape to position your innovation for funding success
86%
Success Rate
Portfolio approach across NIH, NSF, and Canadian health programs
$500K+
HealthTech Secured
Digital health, medical devices, neurotechnology, rehabilitation tech
50%
Faster Process
AI-enhanced drafting + expert review reduces timeline while improving quality
2 Countries
Cross-Border Access
Access both US NIH funding and Canadian health innovation programs
Real Results for Real HealthTech Companies
NEUROTECHNOLOGY
Clinical Trials Initiated
Brain-computer interface technology needed clinical validation funding across 18 months
$42K+ multi-stage NIH SBIR secured
Impact:Clinical trials initiated, enabled Series A funding, now in Phase II trials
"Their understanding of both neuroscience and FDA pathways was crucial."
— CEO, NeuroLink Innovations
DIGITAL HEALTH
Patient Outcomes Validation
Digital therapeutics platform needed patient outcome studies and validation partnerships
$60K+ Canadian health innovation funding
Impact: Clinical validation partnerships secured, healthcare system partnerships worth $2M+ annually
"They helped us navigate both technology and clinical requirements."
— Founder, HealthStream Digital
MEDICAL DEVICES
FDA Pathway Established
Rehabilitation technology needed funding for FDA pathway and clinical studies
$41K+ NSF SBIR Phase I secured
Impact: FDA breakthrough designation achieved, successful licensing partnerships developed
"The regulatory positioning was spot-on for our FDA submission."
— CTO, RehabTech Solutions
Ready to Secure Your HealthTech Funding?
Get a free assessment of your funding opportunities—no sales pitch, just actionable insights
15-minute assessment call
Specific program recommendations
No obligation or sales pitch
How We Secure Your HealthTech Funding
Clinical Assessment
Technology evaluation, regulatory pathway analysis, clinical study design, program prioritization
Strategy Development
Multi-program strategy, regulatory compliance framework, clinical milestone planning
Expert Execution
Clinical narrative development, regulatory positioning, compliance review, submission management
Common Questions
Do you understand FDA regulatory requirements?
Yes, we have experience with FDA pathways and clinical study design requirements.We use a portfolio approach targeting multiple aligned programs rather than single applications.
→ We help position your technology for regulatory success
What if we're still in pre-clinical stages?
We work with companies from concept through clinical trials and commercialization.Most failures come from poor positioning or wrong program selection.
→ Different funding strategies for different development stages
How do you handle clinical study requirements?
We help design study protocols that meet both scientific and funding requirements.From initial assessment to submission typically takes 6-8 weeks.
→ Clinical expertise ensures studies support funding goals
Can you help with international clinical trials?
Yes, we understand both US and Canadian clinical research requirements.Yes, we work with companies from prototype to commercial scale.
→ Cross-border clinical strategies maximize funding opportunities
